Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Yoon

Showing results (921-930 of 954) with videos related to

Pageof 96
Sort By:
Frontiers in Immunology|February 11, 2025
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinomaAngela J Yoon, Richard D Carvajal, Evan M Graboyes, et al.
Cancer Research|February 24, 2018
Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, Sandeep Rajput, Shunqiang Li, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 15, 2019
Diagnostic utility of transcriptome sequencing for rare Mendelian diseasesHane Lee, Alden Y Huang, Lee-Kai Wang, et al.
Cancer Research|December 19, 2024
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal CancerJeremy B Foote, Tyler E Mattox, Adam B Keeton, et al.
The British Journal of Dermatology|September 20, 2011
Clinical characteristics and risk of melanoma development from giant congenital melanocytic naevi in Korea: a nationwide retrospective studyS J Yun, O S Kwon, J H Han, et al.
Blood|September 14, 2013
Clinical and biological implications of driver mutations in myelodysplastic syndromesElli Papaemmanuil, Moritz Gerstung, Luca Malcovati, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI CancerJeremy B Foote, Tyler E Mattox, Adam B Keeton, et al.
Scientific Reports|September 15, 2020
Multi-omic studies on missense PLG variants in families with otitis mediaTori C Bootpetch, Lena Hafrén, Christina L Elling, et al.
BMC Cancer|March 23, 2023
Impact of COVID-19 in patients on active melanoma therapy and with history of melanomaDouglas B Johnson, Michael B Atkins, Cassandra Hennessy, et al.
Tuberculosis (Edinburgh, Scotland)|August 9, 2003
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biologyT C Terwilliger, M S Park, G S Waldo, et al.
Pageof 96

Showing results (921-930 of 954) with videos related to

Sort By:
Pageof 96
Frontiers in Immunology|February 11, 2025
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinomaAngela J Yoon, Richard D Carvajal, Evan M Graboyes, et al.
Cancer Research|February 24, 2018
Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, Sandeep Rajput, Shunqiang Li, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 15, 2019
Diagnostic utility of transcriptome sequencing for rare Mendelian diseasesHane Lee, Alden Y Huang, Lee-Kai Wang, et al.
Cancer Research|December 19, 2024
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal CancerJeremy B Foote, Tyler E Mattox, Adam B Keeton, et al.
The British Journal of Dermatology|September 20, 2011
Clinical characteristics and risk of melanoma development from giant congenital melanocytic naevi in Korea: a nationwide retrospective studyS J Yun, O S Kwon, J H Han, et al.
Blood|September 14, 2013
Clinical and biological implications of driver mutations in myelodysplastic syndromesElli Papaemmanuil, Moritz Gerstung, Luca Malcovati, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI CancerJeremy B Foote, Tyler E Mattox, Adam B Keeton, et al.
Scientific Reports|September 15, 2020
Multi-omic studies on missense PLG variants in families with otitis mediaTori C Bootpetch, Lena Hafrén, Christina L Elling, et al.
BMC Cancer|March 23, 2023
Impact of COVID-19 in patients on active melanoma therapy and with history of melanomaDouglas B Johnson, Michael B Atkins, Cassandra Hennessy, et al.
Tuberculosis (Edinburgh, Scotland)|August 9, 2003
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biologyT C Terwilliger, M S Park, G S Waldo, et al.
Pageof 96